Carl Peters
Overview
Explore the profile of Carl Peters including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
1374
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Selvarajah V, Robertson D, Hansen L, Jermutus L, Smith K, Coggi A, et al.
Kidney Int
. 2024 Sep;
106(6):1170-1180.
PMID: 39218393
Cotadutide is a glucagon-like peptide-1 (GLP-1) and glucagon receptor agonist that may improve kidney function in patients with type 2 diabetes (T2D) and chronic kidney disease (CKD). In this phase...
2.
Lean M, Leslie W, Barnes A, Brosnahan N, Thom G, McCombie L, et al.
Lancet Diabetes Endocrinol
. 2024 Feb;
12(4):233-246.
PMID: 38423026
Background: In DiRECT, a randomised controlled effectiveness trial, weight management intervention after 2 years resulted in mean weight loss of 7·6 kg, with 36% of participants in remission of type...
3.
Shand J, Young S, Verster F, Peters C
BMJ Nutr Prev Health
. 2024 Jan;
6(2):341-346.
PMID: 38264361
Introduction: Diabetes and obesity are significant public health concerns. Previous studies have demonstrated that low energy diets are effective in promoting weight loss and inducing diabetes remission. However, hunger is...
4.
Cassidy S, Trenell M, Stefanetti R, Charman S, Barnes A, Brosnahan N, et al.
Diabet Med
. 2022 Nov;
40(3):e15010.
PMID: 36398460
Aims: As sustained weight loss is vital for achieving remission of type 2 diabetes, we explored whether randomisation to weight loss plus maintenance in the DiRECT trial was associated with...
5.
Jesuthasan A, Zhyzhneuskaya S, Peters C, Barnes A, Hollingsworth K, Sattar N, et al.
Diabetologia
. 2021 Oct;
65(1):226-233.
PMID: 34657182
Aims/hypothesis: Type 2 diabetes confers a greater relative increase in CVD risk in women compared with men. We examined sex differences in intraorgan fat and hepatic VLDL1-triacylglycerol (VLDL1-TG) export before...
6.
Rehackova L, Rodrigues A, Thom G, Brosnahan N, Barnes A, McCombie L, et al.
Diabet Med
. 2021 Sep;
39(1):e14689.
PMID: 34519099
Introduction: The Diabetes REmission Clinical Trial (DiRECT) has shown that sustained remission of type 2 diabetes in primary care is achievable through weight loss using total diet replacement (TDR) with...
7.
Al-Mrabeh A, Peters C, Hollingsworth K, Taylor R
STAR Protoc
. 2021 Mar;
2(1):100355.
PMID: 33733239
Liver fat content and the linked rate of export of triglyceride are central to the etiology of type 2 diabetes, as well as to the cardiovascular effects of fatty liver...
8.
Zhyzhneuskaya S, Al-Mrabeh A, Peters C, Barnes A, Aribisala B, Hollingsworth K, et al.
Diabetes Care
. 2020 Feb;
43(4):813-820.
PMID: 32060017
Objective: To assess functional β-cell capacity in type 2 diabetes during 2 years of remission induced by dietary weight loss. Research Design And Methods: A Stepped Insulin Secretion Test with...
9.
Al-Mrabeh A, Zhyzhneuskaya S, Peters C, Barnes A, Melhem S, Jesuthasan A, et al.
Cell Metab
. 2019 Dec;
31(2):233-249.e4.
PMID: 31866441
The role of hepatic lipoprotein metabolism in diet-induced remission of type 2 diabetes is currently unclear. Here, we determined the contributions of hepatic VLDL1-triglyceride production rate and VLDL1-palmitic acid content...
10.
Lean M, Leslie W, Barnes A, Brosnahan N, Thom G, McCombie L, et al.
Lancet Diabetes Endocrinol
. 2019 Mar;
7(5):344-355.
PMID: 30852132
Background: The DiRECT trial assessed remission of type 2 diabetes during a primary care-led weight-management programme. At 1 year, 68 (46%) of 149 intervention participants were in remission and 36...